These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2236171)

  • 1. Chemotherapy schedules: impact on treatment outcomes and quality of life.
    Tattersall MH
    Prog Clin Biol Res; 1990; 354B():241-9. PubMed ID: 2236171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy in metastasized breast carcinoma: intermittent or continuous?].
    Nortier JW; Rodenburg CJ; Slee PH; Blijham GH
    Ned Tijdschr Geneeskd; 1994 Nov; 138(48):2383-6. PubMed ID: 7990984
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative chemotherapy in the treatment of inflammatory breast cancer.
    Keiling R; Guiochet N; Calderoli H; Hurteloup P; Krzisch C
    Prog Clin Biol Res; 1985; 201():95-104. PubMed ID: 4095121
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy for high-risk operable breast cancer.
    Buzdar AU
    J Clin Oncol; 2007 May; 25(13):1642-4. PubMed ID: 17404366
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction chemotherapy of breast cancer.
    Hortobagyi GN; Buzdar AU; Ames FC; Blumenschein GR; Montague ED
    Prog Clin Biol Res; 1985; 201():105-16. PubMed ID: 4095105
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved outcomes from dose-dense adjuvant chemotherapy for breast cancer with growth factor support.
    Leonard JP
    Curr Hematol Rep; 2003 Nov; 2(6):451-2. PubMed ID: 14561387
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
    Budman DR
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-dose chemotherapy rescued with peripheral blood stem cell transplantation for high-risk patients with breast cancer].
    Kim S; Shiba E; Taguchi T; Kimoto Y; Inoue T; Shimazu K; Takamura Y; Tanji Y; Izukura M; Ogawa H; Sugiyama H; Kubota T; Kimura T; Takai S
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):635-8. PubMed ID: 8678525
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
    Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
    J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of cytostatic drug dose in adjuvant chemotherapy of breast carcinoma].
    Thomssen C
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M102-5. PubMed ID: 8964443
    [No Abstract]   [Full Text] [Related]  

  • 12. Is it time for some new approaches for treating advanced ovarian cancer?
    McGuire WP
    J Natl Cancer Inst; 2006 Aug; 98(15):1024-6. PubMed ID: 16882933
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
    Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
    Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dose-intensive chemotherapy on quality of life.
    Ahles TA
    Lancet Oncol; 2005 May; 6(5):258-9. PubMed ID: 15863373
    [No Abstract]   [Full Text] [Related]  

  • 15. Mathematics and oncology: a match for life?
    Piccart-Gebhart MJ
    J Clin Oncol; 2003 Apr; 21(8):1425-8. PubMed ID: 12668653
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.
    Bottomley A; Biganzoli L; Cufer T; Coleman RE; Coens C; Efficace F; Calvert HA; Gamucci T; Twelves C; Fargeot P; Piccart M;
    J Clin Oncol; 2004 Jul; 22(13):2576-86. PubMed ID: 15226325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New development of treatment for locally advanced breast cancer.
    Pinedo HM
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():272-3. PubMed ID: 10895164
    [No Abstract]   [Full Text] [Related]  

  • 18. Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization.
    Macquart-Moulin G; Viens P; Genre D; Bouscary ML; Resbeut M; Gravis G; Camerlo J; Maraninchi D; Moatti JP
    Cancer; 1999 May; 85(10):2190-9. PubMed ID: 10326697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term tamoxifen therapy for breast cancer.
    Jordan VC
    Important Adv Oncol; 1989; ():179-92. PubMed ID: 2651287
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined modality therapy of locally advanced breast cancer. One institution's experience and a review of the literature.
    Hu E; Stockdale FE; Turner B; Carlson RW; Levine J; Kushlan P
    Anticancer Res; 1987; 7(4B):733-6. PubMed ID: 3314673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.